Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Non-cash Items: 2022-2024

Historic Non-cash Items for Stoke Therapeutics (STOK) over the last 3 years, with Dec 2024 value amounting to $4.3 million.

  • Stoke Therapeutics' Non-cash Items fell 49.16% to $4.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.3 million, marking a year-over-year decrease of 49.16%. This contributed to the annual value of $4.3 million for FY2024, which is 6.29% up from last year.
  • Stoke Therapeutics' Non-cash Items amounted to $4.3 million in FY2024, which was up 6.29% from $4.0 million recorded in FY2023.
  • In the past 5 years, Stoke Therapeutics' Non-cash Items ranged from a high of $4.3 million in FY2024 and a low of $4.0 million during FY2023.
  • For the 3-year period, Stoke Therapeutics' Non-cash Items averaged around $4.2 million, with its median value being $4.3 million (2022).
  • As far as peak fluctuations go, Stoke Therapeutics' Non-cash Items decreased by 5.88% in 2023, and later increased by 6.29% in 2024.
  • Over the past 3 years, Stoke Therapeutics' Non-cash Items (Yearly) stood at $4.3 million in 2022, then decreased by 5.88% to $4.0 million in 2023, then increased by 6.29% to $4.3 million in 2024.